»
Antikörper
»
anti-P21-WAF1
P21/WAF1 Antikörper
| Antigen |
|
| Klonalität |
Monoklonal (WA-1) |
|
Wirt
|
|
|
Reaktivität
|
|
|
Applikation
|
Alternativen Western Blot (WB), Immunhistochemie (Paraffinschnitte) (IHC (p)), ELISA, Immunzytochemie (ICC)
|
| Produktnummer |
ABIN94444 |
| Menge |
0.1 mg (1 mg/ml) |
| Preis |
200,00 € Zzgl. Versandkosten €20,00 und MWSt
|
| Lieferung nach |
|
| Verfügbarkeit |
Lieferbar innerhalb von 3 bis 5 Werktagen |
|
Weitere Bezeichnung
|
p21Waf1
|
|
Immunogen
|
Human p21 protein
|
|
Format
|
Purified
|
|
Isotyp
|
IgG1 (Passende Sekundärantikörper)
|
|
Klon
|
WA-1
|
|
Beschreibung
|
The tumour suppressor p21Waf1 (Wild-type p53-Activated Fragment 1, also known as Cip1,Cdk interacting protein, or SDI 1) is a cyclin-dependent kinase (Cdk) inhibitor, which isexpressed by involvement of p53, Egr-1, AP2, STATs or other transcription factors uponvarious stimuli resulting in cell cycle arrest. Through its N-terminal domain p21Waf1 inhibitsCdk activity, whereas through the C-terminal domain it inhibits the activity of PCNA(proliferating cell nuclear antigen) to activate DNA replication. Cytosolic location of p21counteracts its inhibitory activities.
|
|
Spezifität
|
The antibody WA-1 reacts with p21 protein (Waf1, Cip1, SDI 1), a 21 kDa tumoursuppressor, which inhibits the activity of cyclin-dependent family kinases and of proliferatingcell nuclear antigen.
|
|
Applikationshinweise
|
Immunohistochemistry (paraffin sections) - Positive tissue: colon carcinomaImmunocytochemistryELISA
|
|
Konzentration
|
1 mg/ml
|
|
Reinheit
|
> 95% (by SDS-PAGE)
|
|
Reinigung
|
Purified from ascites by precipitation methods.
|
|
Buffer
|
Phosphate buffered saline (PBS) with 15 mM sodium azide, approx. pH 7.4
|
|
Lagerung
|
Store at 2-8 o C. Do not use after expiration date stamped on vial label. For long-term storage aliquot and store at -20 o C. Avoid freeze/thaw cycles.
|
|
Beschränkungen
|
Nur für Forschungszwecke einsetzbar
|
Alternativen zu Antigen "P21/WAF1", Typ "Antikörper" finden